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Abstract  
 
    Genetic loci explain only 25-30% of the heritability observed in plasma lipid traits. 
Epistasis, or gene-gene interactions may contribute to a portion of this missing 
heritability. Using genetic data from five NHLBI cohorts of 24,837 individuals, we 
combined the use of the quantitative multifactor dimensionality reduction (QMDR) 
algorithm with two SNP filtering methods to exhaustively search for SNP-SNP 
interactions that are associated with HDL cholesterol (HDL-C), LDL cholesterol (LDL-
C), total cholesterol (TC) and triglycerides (TG). SNPs were filtered either on the 
strength of their independent effects (main effect filter) or the prior knowledge supporting 
a given interaction (Biofilter). After the main effect filter, QMDR identified 20 SNP-SNP 
models associated with HDL-C, 6 associated with LDL-C, 3 associated with TC, and 10 
associated with TG (permutation P-value < 0.05). With the use of Biofilter, we identified 
2 SNP-SNP models associated with HDL-C, 3 associated with LDL-C, 1 associated with 
TC and 8 associated with TG (permutation P-value < 0.05). In an independent dataset of 
7,502 individuals from the eMERGE network, we replicated 14 of the interactions 
identified after main effect filtering: 11 for HDL-C, 1 for LDL-C and 2 for TG. We also 
replicated 23 of the interactions found to be associated with TG after applying Biofilter. 
Prior knowledge supports the possible role of these interactions in the genetic etiology of 
lipid traits. This study also presents a computationally efficient pipeline for analyzing 
data from large genotyping arrays and detecting SNP-SNP interactions that are not 
primarily driven by strong main effects.  
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Introduction 
    Plasma lipid and lipoprotein levels are a major risk factor for cardiovascular disease 
(CVD), the leading cause of death in the world (Arsenault et al. 2011; World Health 
Organization 2014). In 2012, approximately one-third of all global deaths were caused by 
CVD (Deaton et al. 2011; World Health Organization 2014). Moreover, CVD no longer 
remains a disease associated with industrialized nations. With increasing urbanization 
around the world, 80% of global CVD-related deaths occur in low- and middle-income 
countries and the World Health Organization estimates global CVD-related deaths to 
reach 22.2 million by 2030 (World Health Organization 2014). 
 
    Although lipid levels can be influenced by factors such as age, sex, body mass index 
(BMI), environmental factors and lifestyle choices including diet, they can be influenced 
by genetic factors as well (Heller et al. 1993). Lipid traits such as high density lipoprotein 
cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), total cholesterol (TC) 
and triglyceride (TG) levels have been shown to have heritability estimates ranging 
between 40% to 60% (Weiss et al. 2006).  
 
  Various genetic loci associated with lipid traits have been identified by genome-wide 
association studies (GWAS); however, these loci only explain 25-30% of the heritability 
observed in plasma lipid traits (Kathiresan et al. 2009; Teslovich et al. 2010). Epistasis, 
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or interactions between genes, may help to explain a portion of the missing heritability of 
lipid traits (Manolio et al. 2009) and studies are needed to examine the genomic context 
of single nucleotide polymorphisms (SNPs) by specifically searching for non-linear 
interactions between them (Eichler et al. 2010). 
 
    Exhaustively searching for interactions between SNPs in large datasets generated with 
genotyping arrays leads to a prohibitive number of statistical tests and is computationally 
expensive (Moore et al. 2010). Although other approaches such as BOOST and MB-
MDR are significant alternatives that enable researchers to perform a genome-wide 
analysis for gene-gene interactions – they were not an ideal fit for the purposes of this 
study. For example, the BOOST method can only analyze binary phenotypes (Wan et al. 
2010). Additionally, the MB-MDR method relies on performing a chi-square test, which 
can be ineffective when contingency tables become sparse (Calle et al. 2010). 
Researchers have also reported on the computational intensity required to perform a 
genome wide screening using MB-MDR (Gundlach et al. 2016). 
 
In this study, we addressed these bioinformatics challenges by applying SNP-filtering 
methods along with the quantitative multifactor dimensionality reduction (QMDR) 
machine learning algorithm to the analysis of lipid traits for the first time. We aimed to 
identify interactions between SNPs that are associated with four lipids traits (HDL-C, 
LDL-C, TC and TG) across five National Heart, Lung and Blood Institute (NHLBI) study 
cohorts. These SNPs have also been analyzed as part of a previous large-scale study 
aimed at identifying independent signals associated with multiple lipid traits using 
regression methods. This study identified 21 novel loci that had not been found to be 
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associated with lipid traits before. The study also replicated a large number of previously 
implicated signals associated with lipid traits (Asselbergs et al. 2012).   
 
Results 
 
Main effect filter 
 
    The main effect filter resulted in a final list of 486 markers to be tested for SNP-SNP 
interactions for HDL-C, 462 markers for LDL-C, 571 markers for TC and 502 markers 
for TG. After QMDR analysis, at a permutation P-value  < 0.05, we identified 20 SNP-
SNP interaction models that were associated with HDL-C (Table 1), 6 SNP-SNP 
interaction models associated with LDL-C (Table 1), 3 SNP-SNP interaction models 
associated with TC (Table 1), and 10 SNP-SNP models associated with TG (Table 1).  
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Table 1 Results from QMDR association analysis of Main effect filter SNPs for lipid traits 
 
SNP1 Chr:bp Gene1 
SNP1 
Function 
SNP1 Main 
Effect  
P-Value 
SNP2 Chr:bp Gene2 
SNP2 
Function 
SNP2 Main 
Effect  
P-Value 
Interaction 
Permuted  
P-Value 
HDL-C 
rs4783961 16:55552395 CETP Exonic 1.286E-51 rs1800775 16:55552737 CETP Exonic 2.46E-196 < 0.00001 
rs12720918 16:55551713 CETP Exonic 3.15E-79 rs158477 16:55565111 CETP Intronic 3.747E-12 < 0.00001 
rs4783961 16:55552395 CETP Exonic 1.286E-51 rs1864163 16:55554734 CETP Intronic 5.33E-185 < 0.00001 
rs12720918 16:55551713 CETP Exonic 3.15E-79 rs4783961 16:55552395 CETP Exonic 1.286E-51 < 0.00001 
rs1864163 16:55554734 CETP Intronic 5.33E-185 rs4784744 16:55568686 CETP Intronic 1.86E-36 < 0.00005 
rs12708967 16:55550712 CETP Exonic 8.5E-102 rs820299 16:55557785 CETP Intronic 2.457E-16 < 0.00024 
rs12447924 16:55551693 CETP Exonic 3.48E-18 rs9939224 16:55560233 CETP Intronic 2.1E-172 < 0.00031 
rs4783961 16:55552395 CETP Exonic 1.286E-51 rs158477 16:55565111 CETP Intronic 3.747E-12 < 0.00087 
rs1864163 16:55554734 CETP Intronic 5.33E-185 rs158477 16:55565111 CETP Intronic 3.747E-12 < 0.00104 
rs1864163 16:55554734 CETP Intronic 5.33E-185 rs820299 16:55557785 CETP Intronic 2.457E-16 0.00405 
rs4783961 16:55552395 CETP Exonic 1.286E-51 rs9939224 16:55560233 CETP Intronic 2.1E-172 < 0.00525 
rs1800775 16:55552737 CETP Exonic 2.46E-196 rs820299 16:55557785 CETP Intronic 2.457E-16 < 0.0083 
rs12744291 1:66135559 PDE4B Intronic 0.002352 rs1010554 3:52517959 STAB1 Intronic 0.0004028 < 0.00873 
rs230541 4:103716823 NFKB1 Intronic 0.001379 rs4935047 10:54200073 MBL2 Intronic 0.002622 0.01116 
rs12976922 19:60562163 COX6B2 Exonic 0.006489 rs2952101 X:14768515 FANCB Intronic 0.001637 < 0.0119 
rs9644636 8:19869176 LPL Exonic 3.031E-12 rs7013777 8:19922636 LPL - 7.58E-26 < 0.01719 
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rs9939224 16:55560233 CETP Intronic 2.1E-172 rs4784744 16:55568686 CETP Intronic 1.86E-36 0.01843 
rs599839 1:109623689 PSRC1 Exonic 1.967E-07 rs2952101 X:14768515 FANCB Intronic 0.001637 0.02954 
rs12708967 16:55550712 CETP Exonic 8.5E-102 rs158477 16:55565111 CETP Intronic 3.747E-12 0.03023 
rs3870336 3:49532861 DAG1 Intronic 0.001736 rs6641322 X:149494622 IDS Intronic 0.005715 < 0.04418 
LDL-C 
rs157580 19:50087106 TOMM40 Intronic 5.623E-38 rs439401 19:50106291 APOE Intronic 0.002661 < 0.00522 
rs17435152 7:40568630 C7orf10 Intronic 0.004781 rs3764261 16:55550825 CETP - 0.000001483 0.00743 
rs157580 19:50087106 TOMM40 Intronic 5.623E-38 rs405509 19:50100676 APOE Exonic 1.503E-33 0.00781 
rs12811752 12:20469072 PDE3A Intronic 0.00391 rs1469713 19:19389806 GATAD2A Intronic 0.00007551 < 0.01293 
rs480780 13:32505319 KL Intronic 0.00008468 rs2965174 19:49936855 BCL3 Exonic 0.000003422 0.02482 
rs625619 1:55290754 PCSK9 Intronic 0.000398 rs3764261 16:55550825 CETP - 0.000001483 0.03809 
TC 
rs693 2:21085700 APOB Exonic 2.057E-44 rs661665 2:21118646 APOB Intronic 0.0005396 < 0.00835 
rs12898801 15:56585846 LIPC Intronic 0.009846 rs953065 15:87203929 ACAN Intronic 0.002909 < 0.01297 
rs10744777 12:110717401 ALDH2 Intronic 0.002676 rs749767 16:31031908 BCKDK Exonic 0.003476 0.01975 
TG 
rs2075295 11:116133611 BUD13 Intronic 0.000001359 rs6589568 
11:11617594
8 
APOA5 - 5.402E-20 < 0.00001 
rs4938303 11:116090197 BUD13 - 9.893E-73 rs180327 
11:11612886
9 
BUD13 Intronic 1.75E-45 < 0.00001 
rs180327 11:116128869 BUD13 Intronic 1.75E-45 rs2075295 
11:11613361
1 
BUD13 Intronic 0.000001359 < 0.00007 
rs180327 11:116128869 BUD13 Intronic 1.75E-45 rs10750097 
11:11616925
0 
APOA5 Exonic 3.56E-97 < 0.00027 
9 
rs11216129 11:116125466 BUD13 Intronic 0.000005043 rs10750097 
11:11616925
0 
APOA5 Exonic 3.56E-97 < 0.00516 
rs609526 1:228375529 GALNT2 Intronic 0.002831 rs12257915 10:90982709 LIPA Intronic 0.005381 < 0.03321 
rs2075295 11:116133611 BUD13 Intronic 0.000001359 rs10750097 
11:11616925
0 
APOA5 Exonic 3.56E-97 < 0.03351 
rs4938303 11:116090197 BUD13 - 9.893E-73 rs6589568 
11:11617594
8 
APOA5 - 5.402E-20 < 0.03379 
rs174455 11:61412693 FADS3 Intronic 3.106E-07 rs689243 
11:11622790
3 
KIAA0999 Intronic 8.632E-24 < 0.03789 
rs180327 11:116128869 BUD13 Intronic 1.75E-45 rs618923 
11:11615936
9 
ZNF259 Intronic 6.708E-20 < 0.03833 
 
Signals reached a permutation P-value < 0.05. SNPs have been mapped to their corresponding genes using dbSNP (build 139). SNP1 and SNP2 
indicate the individual SNPs within a given SNP-SNP interaction model. Chromosomal location of SNPs is noted in the following format - 
Chromosome:Base pair. Functional consequences were identified using dbSNP. Information for some SNPs was not available. P-values were 
calculated from a distribution built from 1000 permutations.  
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     In the case of HDL-C, a large number of the identified SNP-SNP models represent 
intra-genic interactions within CETP. Fig. 1 shows the underlying LD structure of these 
interactions. None of the interacting SNPs were in strong LD (r2 > 0.8). Moreover, none 
of the identified pairwise interactions for each of the quantitative lipid traits exhibited 
strong LD (Figs. S1-3). 
 
Biofilter 
 
    The Biofilter procedure resulted in a final list of 1,811 markers (22,487 SNP-SNP 
models) for HDL-C, 1,812 markers (22,491 SNP-SNP models) for LDL-C, 1,812 
markers (22,454 SNP-SNP models) for TC and 1,811 markers (22,487 SNP-SNP models) 
for TG. QMDR analysis identified 14 significant SNP-SNP models with a permutation P-
value < 0.05: 2 SNP-SNP models associated with HDL-C, 3 SNP-SNP models associated 
with LDL-C, 1 SNP-SNP model associated with TC and 8 SNP-SNP models associated 
with TG (Table 2). None of the interacting SNPs were found to be in strong LD in this 
case as well (Figs. S4-7).  
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Table 2 Results from QMDR association analysis of Biofilter SNPs for lipid traits 
SNP1 Chr:bp Gene1 
SNP1 
Function 
SNP2 Chr:bp Gene2 
SNP2 
Function 
Permuted P-
Value 
HDL-C 
rs17496549 6:32517686 HLA-DRA Intronic rs615672 6:32682149 HLA-DRB1 - < 0.01178 
rs549888 6:33660180 GGNBP1 Intronic rs7240326 18:59068331 BCL2 Intronic 0.0404 
LDL-C 
rs39499 8:90839744 RIPK2 Intronic rs751919 16:49333246 CYLD Intronic 0.03262 
rs12693591 2:191568747 STAT1 Intronic rs8072566 17:37729889 STAT3 Intronic 0.04211 
rs2066795 2:191560142 STAT1 Intronic rs8074524 17:37723124 STAT3 Intronic < 0.04788 
TC 
rs4725431 7:151104112 PRKAG2 Intronic rs10875915 12:47716361 MLL2 Intronic < 0.04276 
TG 
rs9521510 13:109224872 IRS2 Intronic rs2860184 19:7238748 INSR Intronic < 0.00079 
rs9521510 13:109224872 IRS2 Intronic rs6510976 19:7217944 INSR Intronic < 0.00289 
rs2075110 7:55186653 EGFR Intronic rs4789172 17:70853307 GRB2 Intronic < 0.00385 
rs4773088 13:109219885 IRS2 Intronic rs4804404 19:7169382 INSR Intronic < 0.00401 
rs7999797 13:109224001 IRS2 Intronic rs8109559 19:7122629 INSR Intronic 0.01758 
rs4771646 13:109225180 IRS2 Intronic rs4804404 19:7169382 INSR Intronic < 0.02007 
rs1729409 11:116178978 APOA5 - rs11216162 11:116233487 KIAA0999 Intronic < 0.02063 
rs7999797 13:109224001 IRS2 Intronic rs7252268 19:7121505 INSR Intronic < 0.03164 
Signals reached a permutation P-value < 0.05. SNPs have been mapped to their corresponding genes using dbSNP (build 139). SNP1 and SNP2 indicate the 
individual SNPs within a given SNP-SNP interaction model. Chromosomal location of SNPs is noted in the following format - Chromosome:Base pair. P-values 
were calculated from a distribution built from 1000 permutations.
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Replication analyses 
 
    After following an identical QMDR analysis procedure, we were able to replicate 
SNP-SNP models in the eMERGE dataset at a permutation P-value threshold of 0.05. 
Eleven main effect filtered SNP-SNP models were replicated for HDL-C, 1 main effect 
filtered SNP-SNP model for LDL-C and 2 such models for TG (Table 3).  Additionally, 
23 Biofilter SNP-SNP models replicated for TG (Table 3).  
 
Added variance in lipid traits explained 
 
    The adjusted R2 values and associated likelihood ratio test P-values are as follows: 
Main effect filter: HDL full = 0.03355578, HDL reduced = 0.03181211 (P-value = 0.01); 
LDL full = 0.01514733, LDL reduced = 0.01355952 (P-value = 0.002); TG full = 
0.007837119, TG reduced = 0.00765267 (P-value = 0.2). Biofilter: TG full = -
0.001432491, TG reduced = -0.0005782882 (P-value = 0.9). Although in most cases the 
inclusion of interacting SNPs showed an increase in the variance explained, the 
difference was statistically significant for the HDL and LDL main effect analyses.  
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Table 3 Results from QMDR association analysis of main effect and Biofilter SNP-SNP models replicated in eMERGE dataset  
Rank Model SNP1 Chr:bp Gene1 SNP2 Chr:bp Gene2 
Permuted 
P-Value 
Main effect filter: HDL Cholesterol Levels 
1 rs4783961,rs1800775 rs4783961 16:55552395 CETP rs1800775 16:55552737 CETP < 0.00001 
2 rs4783961,rs3816117 rs4783961 16:55552395 CETP rs3816117 16:55553659 CETP < 0.00001 
3 rs4783961,rs1532624 rs4783961 16:55552395 CETP rs1532624 16:55562980 CETP < 0.00001 
4 rs4783961,rs1532625 rs4783961 16:55552395 CETP rs1532625 16:55562802 CETP < 0.00001 
5 rs4783961,rs7205804 rs4783961 16:55552395 CETP rs7205804 16:55562390 CETP < 0.00001 
6 rs4783961,rs711752 rs4783961 16:55552395 CETP rs711752 16:55553712 CETP < 0.00001 
7 rs4783961,rs708272 rs4783961 16:55552395 CETP rs708272 16:55553789 CETP < 0.00001 
8 rs1864163,rs289717 rs1864163 16:55554734 CETP rs289717 16:55566889 CETP < 0.00004 
9 rs1864163,rs4784744 rs1864163 16:55554734 CETP rs4784744 16:55568686 CETP < 0.00004 
10 rs1864163,rs291044 rs1864163 16:55554734 CETP rs291044 16:55568953 CETP < 0.00004 
11 rs4783961,rs1864163 rs4783961 16:55552395 CETP rs1864163 16:55554734 CETP < 0.00229 
Main effect filter: LDL Cholesterol Levels 
1 rs157580,rs405509 rs157580 19:50087106 TOMM40 rs405509 19:50100676 APOE < 0.00488 
Main effect filter: Triglyceride Levels 
1 rs180327,rs618923 rs180327 11:116128869 BUD13 rs618923 11:116159369 ZNF259 < 0.31483 
2 rs180326,rs618923 rs180326 11:116129913 BUD13 rs618923 11:116159369 ZNF259 < 0.33204 
Biofilter: Triglyceride Levels 
1 rs9521510,rs6510976 rs9521510 13:109224872 IRS2 rs6510976 19:7217944 INSR < 0.01014 
2 rs35612086,rs6510976 rs35612086 13:109244865 IRS2 rs6510976 19:7217944 INSR < 0.01155 
3 rs36092351,rs6510976 rs36092351 13:109246741 IRS2 rs6510976 19:7217944 INSR < 0.01163 
4 rs2117455,rs6510976 rs2117455 13:109241895 IRS2 rs6510976 19:7217944 INSR < 0.01166 
5 rs9521517,rs6510976 rs9521517 13:109245638 IRS2 rs6510976 19:7217944 INSR < 0.01166 
6 rs1414316,rs6510976 rs1414316 13:109248190 IRS2 rs6510976 19:7217944 INSR < 0.01168 
7 rs9521510,rs6510975 rs9521510 13:109224872 IRS2 rs6510975 19:7217878 INSR < 0.01259 
14 
8 rs9515119,rs6510975 rs9515119 13:109207337 IRS2 rs6510975 19:7217878 INSR < 0.01643 
9 rs9515119,rs6510976 rs9515119 13:109207337 IRS2 rs6510976 19:7217944 INSR < 0.01657 
10 rs2289046,rs6510975 rs2289046 13:109205907 IRS2 rs6510975 19:7217878 INSR < 0.01657 
11 rs2289047,rs6510975 rs2289047 13:109205816 IRS2 rs6510975 19:7217878 INSR < 0.01657 
12 rs2289046,rs6510976 rs2289046 13:109205907 IRS2 rs6510976 19:7217944 INSR 0.01680 
13 rs2289047,rs6510976 rs2289047 13:109205816 IRS2 rs6510976 19:7217944 INSR 0.01680 
14 rs4771649,rs6510976 rs4771649 13:109248514 IRS2 rs6510976 19:7217944 INSR < 0.01709 
15 rs35612086,rs6510975 rs35612086 13:109244865 IRS2 rs6510975 19:7217878 INSR < 0.02214 
16 rs36092351,rs6510975 rs36092351 13:109246741 IRS2 rs6510975 19:7217878 INSR < 0.02220 
17 rs2117455,rs6510975 rs2117455 13:109241895 IRS2 rs6510975 19:7217878 INSR < 0.02223 
18 rs9521517,rs6510975 rs9521517 13:109245638 IRS2 rs6510975 19:7217878 INSR 0.02223 
19 rs1414316,rs6510975 rs1414316 13:109248190 IRS2 rs6510975 19:7217878 INSR < 0.02225 
20 rs2075110,rs4789172 rs2075110 7:55186653 EGFR rs4789172 17:70853307 GRB2 < 0.02793 
21 rs4771649,rs6510975 rs4771649 13:109248514 IRS2 rs6510975 19:7217878 INSR 0.03304 
22 rs2075109,rs4789172 rs2075109 7:55186397 EGFR rs4789172 17:70853307 GRB2 0.04293 
23 rs9521518,rs6510976 rs9521518 13:109251997 IRS2 rs6510976 19:7217944 INSR 0.04882 
 
Shown here are models that reached a permutation P-value < 0.05 in the replication dataset. SNPs have been mapped to their 
corresponding genes using dbSNP (build 139). SNP1 and SNP2 indicate the individual SNPs within a given SNP-SNP interaction 
model. . Chromosomal location of SNPs is noted in the following format - Chromosome:Base pair.  P-values were calculated from a 
distribution built from 1000 permutations.  
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Discussion 
 
    Although many researchers acknowledge the need for embracing the complexity of the 
genotype-phenotype relationship by studying gene-gene interactions, exploring epistasis 
in large genotyping arrays presents a biostatistical and computational challenge. These 
challenges call for new computational methods since more traditional approaches such as 
general linear models may have limited power when modeling high-dimensional data. 
The use of SNP-filtering methods has been presented as a suitable solution to ease the 
computational burden of exhaustively searching for all possible interactions between 
large numbers of SNPs (Moore et al. 2010).  
 
    In our analyses, we combined genotypic and phenotypic information for four 
quantitative lipid traits – HDL-C, LDL-C, TC and TG – for 24,837 individuals from five 
study cohorts. We reduced the number of interactions tested by filtering SNPs either 
based on the strength of their independent effects or the strength of relevant prior 
biological knowledge. Filtered SNPs were tested for two-way SNP-SNP interactions 
associated with each quantitative lipid trait using QMDR.  
 
    SNPs tested from the main effect filter and Biofilter methods showed only 2-3% 
overlap in each of the four lipid traits (HDL: 35 SNPs, LDL: 40 SNPs, TC: 64 SNPs, TG: 
52 SNPs). None of these overlapping SNPs were part of the SNP x SNP interactions 
replicated in the eMERGE dataset. However, two biological pathways highlighted by 
these overlapping SNPs were identified by our replicated genetic interactions as well. For 
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example, there is overlap in the hepatic insulin signaling pathway and its relationship 
with lipogenesis, as highlighted by INSR and IRS2. The growth factor signaling 
relationship between EGFR and GRB2 is also captured by the overlapping SNPs. 
 
    We also evaluated how much of the explained phenotypic variance of the four 
quantitative lipid traits could be increased by the SNP-SNP interactions we replicated. 
We found statistically significant increases in the variance explained for HDL (5.5%) and 
LDL (11.7%) in our main effect filter analyses, beyond what is explained by the main 
effects of SNPs within these replicated interactions.  
 
    Below we highlight the potential biological functions for several genes at or near the 
identified interacting SNPs. Further details regarding the biological roles and functions 
associated with all genes at or near these interactions are listed in Table S1.  
 
HDL-C 
 
      In our analysis, the 25 total SNPs that we identified to interact significantly with each 
other, were in or near 15 genes. Ten SNPs were located at or near CETP, which is 
involved in the transfer of cholesteryl ester from HDL to other lipoproteins (Barter et al. 
2003). Moreover, we identified 12 intra-genic interactions between independent SNPs 
within the CETP region (Table 1). Three of the original intra-genic CETP interactions 
(interactions 1, 9 and 11 in Table 3) and 8 additional LD expanded interactions were 
replicated in the eMERGE dataset. Though the impact of these intra-genic regions on 
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HDL-C is unknown, they may act through regulatory or epigenetic mechanisms (Soto-
Ramírez et al. 2013; Olsson et al. 2014). 
 
    Some of the other identified genes also have well studied roles in lipid and cholesterol 
metabolism such as – LPL and PSRC1 (Brown et al. 1989; Kuivenhoven et al. 1997). 
Both genes were identified in interactions in the discovery dataset only. Two SNPs were 
at or near LPL; mutations in LPL are linked to various disorders of lipoprotein 
metabolism and have been previously reported to alter HDL-C levels (Reymer et al. 
1995; Wittekoek et al. 1998). We also identified one intra-genic interaction within LPL 
(Table 1). Lastly, 1 SNP was near PSRC1. Variations within PSRC1 have also been 
shown be associated with cholesterol traits in previous GWA studies (Kathiresan et al. 
2008a; Ma et al. 2010; Voight et al. 2012).  
 
     The IMP network of genes represented in main effect filtered SNP-SNP models 
associated with HDL-C, includes genes from replicated and non-replicated interactions. 
The interaction between PSRC1 with BRCA1 via AURKA in this network, highlights a 
potentially interesting biological connection between dyslipidemia and breast cancer (Fig. 
2a). High cholesterol has been highlighted as a risk factor for breast cancer and various 
mechanisms linking the two diseases have been hypothesized and studied (Nelson et al. 
2014). The interaction between PSRC1 and AURKA in this network reflects their well-
known role in spindle organization. There was also strong support for the interaction 
between AURKA and BRCA1. This is not surprising since, AURKA is a known to be an 
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activator of Akt (Yao et al. 2009) – a kinase involved in tumor cell growth (Paplomata 
and O’Regan 2014).  
 
LDL-C 
 
    We identified 16 total SNPs to interact significantly with each other, located in or near 
13 genes. These findings included two SNP-SNP models representing interactions 
between the genes TOMM40 and APOE. One of these interaction models replicated in the 
eMERGE dataset (Table 3). The TOMM40/APOE-C1-C2-C4 gene cluster has been 
shown to affect LDL-C levels previously (Klos et al. 2008; Middelberg et al. 2011). In 
the IMP network built from SNP-SNP models identified after main effect filtering, there 
is strong support for the interaction between TOMM40 and FARSA, which encodes for 
the alpha subunit of a phenylalanyl-tRNA synthetase (Fig. 2b). FARSA is also involved 
in a protein-protein interaction with the ECSIT signaling integrator, which in turn 
interacts with APOE. Furthermore, APOE interacts with LDLR in the network, 
highlighting their shared role in sterol transport and cholesterol homeostasis (Fig. 2b). 
LDLR, which encodes for the LDL receptor, also interacts with PCSK9 in the network 
since both genes share a role in cholesterol homeostasis (Fig. 2b). PCSK9 binds LDLR 
and promotes degradation of the LDL receptor either in the lysosome or in the liver (Cao 
et al. 2011). Hence, due to its inhibitory role with LDLR, it has emerged as an attractive 
drug target for hypercholesterolemia (Akram et al. 2010).  
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    The IMP network also had an enrichment of processes such as - cholesterol and lipid 
homeostasis, cholesterol transport, regulation of plasma lipoprotein particle levels, 
plasma lipoprotein particle clearance, and low density lipoprotein particle receptor 
catabolic process. The genes involved in these processes included APOE, CETP and 
PCSK9. SNPs within these genes have been previously found to be associated with LDL-
C (Talmud et al. 2009).  
 
Total Cholesterol 
 
    There were 3 SNP-SNP interactions that were significantly associated with TC after 
main effect filtering. An intra-genic interaction within APOB was most significantly 
associated with TC after main effect filtering, although it did not replicate in the 
eMERGE dataset. Mutations within APOB can cause familial defective apolipoprotein B-
100 (FDB) – an inherited form of hypercholesterolemia (Hooper et al. 2005). The protein 
encoded by this gene forms the building block for various types of low-density 
lipoproteins. It is also involved in cholesterol homeostasis and sterol transport. 
Researchers have also found a polymorphism on this gene to increase LDL-C levels 
(Benn et al. 2005).  
 
    There was one significant SNP-SNP interaction associated with TC after Biofilter 
filtering which also did not replicate in the eMERGE dataset. The gene-gene interaction 
between MLL2 and PRKAG2 highlights biological processes such as histone methylation, 
protein alkylation and protein methylation (Wong et al. 2012). MLL2, which codes for a 
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mixed-lineage leukemia histone methylase, contributes to the activation of SR-B1. SR-B1 
is a class-B type-1 scavenger receptor responsible for maintaining blood cholesterol 
levels (Ansari et al. 2012). PRKAG2 encodes for the regulatory γ2 subunit of an AMP-
activated protein kinase. Homozygotes of an intronic SNP within this gene have been 
found to have elevated serum concentrations of TC and TG (Xu et al. 2005).  
 
Triglycerides 
 
    We found an interaction between BUD13 and ZNF259. This interaction and an LD-
expanded SNP-SNP model representing it were replicated in the eMERGE dataset (Table 
3). An interaction between variants on these two genes has been found to be associated 
with TG and TC before (Aung et al. 2014). Moreover, many studies have found 
polymorphisms within BUD13 to be associated with TG (Kathiresan et al. 2008b; 
Waterworth et al. 2010; Aung et al. 2014). BUD13 encodes for the BUD13 homolog 
protein. It is part of the RES complex that was originally identified as a splicing factor in 
yeast and shown to affect nuclear pre-mRNA retention (Brooks et al. 2009).  
 
    Six of the eight SNP-SNP interactions associated with TG after Biofilter filtering, 
represent an interaction between the genes INSR and IRS2. Twenty-one models 
representing this SNP-SNP interaction were identified in the eMERGE dataset as well 
(Table 3). This included two of the original SNP-SNP interactions between these genes 
(interactions 1 and 20 in Table 3). INSR encodes for the insulin receptor, which works 
with the IRS2 molecule in hepatic insulin signaling. Insulin is also known to activate 
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lipogenesis within the liver. Moreover, an inverse relationship between IRS2 and SREBP-
1 gene expression has been demonstrated (Ide et al. 2004). SREBPs are transcription 
factors that are involved in the expression of various genes involved in the synthesis of 
triglycerides (Horton et al. 2002).  
 
Strengths and Limitations 
 
    Despite the computational and biostatistical challenges of investigating gene-gene 
interactions in datasets from large genotyping arrays, we have established an efficient 
analytic framework to overcome the limited power of traditional statistical methods when 
modeling high-dimensional data. The use of knowledge-based filtering methods within 
our framework improved our ability to identify biologically relevant interactions in the 
context of lipid phenotypes. 
 
    However, our methods are limited by the strength of the knowledge of gene functions 
available in public databases. Our replication sample was small which could have 
decreased our power to replicate the interactions we identified in our discovery dataset. 
Additionally, the genetic similarity and the underlying LD structures of our study 
population and that of the reference groups can affect our genotype imputation results. 
However, we attempted to address these biases through the use of cosmopolitan reference 
panels (Verma et al. 2014). Lastly, although the use of SNP-filtering methods have been 
suggested as a favorable solution for reducing the computational burden of studying 
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epistasis in such large datasets, they do introduce their own biases into the study, which 
have been discussed previously (Ritchie 2011).  
 
    The use of traditional statistical methods focusing on main effects has been able to 
explain only a portion of the heritability of lipid traits. We performed a comprehensive 
analysis by examining gene-gene interactions within four quantitative lipid traits – HDL-
C, LDL-C, TC and TG, from five study cohorts. With the use of machine learning 
algorithms such as QMDR, a targeted gene-centric genotypic chip and SNP-filtering 
methods, we identified multiple gene-gene interactions associated with these lipid traits. 
Existing knowledge suggests potentially important roles for these genes in the 
pathobiology of lipid traits. Ultimately, the true effect of these interactions will have to be 
validated at the bench.  
 
Subjects and Methods 
 
Participating Cohorts 
 
   The overall study design is shown in Fig. 3. Genotype and phenotype information was 
combined from the following studies: Atherosclerosis Risk in Communities (ARIC) (Hill 
et al. 1989); Coronary Artery Risk Development in Young Adults (CARDIA) (Friedman 
et al. 1988); Cardiovascular Health Study (CHS) (Fried et al. 1991); Framingham Heart 
Study (FHS) (Dawber et al. 1951); and Multi-Ethnic Study of Atherosclerosis (MESA) 
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(Bild et al. 2002) (Table S2), resulting in an initial sample size of 24,837 individuals of 
self-reported European ancestry. 
 
    The eMERGE I-660 dataset was used for replication analyses (McCarty et al. 2011). 
This dataset was imputed using data from the 1000 Genomes Project (Verma et al. 2014). 
Detailed information regarding the replication dataset is presented in Table S3. 
 
Phenotypic outcomes measured 
 
     HDL-C, LDL-C, TC and TG levels were measured from baseline or first measurement 
blood samples. All measurements were converted to mmol/L. LDL-C was calculated 
according to Friedewald’s formula (Friedewald et al. 1972):  
L ~ C – H – kT 
 
where C is total cholesterol, H is HDL, L is LDL, T is triglycerides, and k is 0.45 for 
mmol/L. If TG values were > 4.51 mmol/L, then LDL was treated as a missing value. 
Additionally, TG values were transformed for normality.  
 
Genotyping and quality control 
 
     Study participants in the discovery dataset were genotyped using the gene-centric 
ITMAT-Broad-CARe (IBC) array. The IBC array contains 47, 451 SNPs and it was 
designed to test ~ 2,100 loci that have been implicated in various cardiovascular, 
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metabolic and inflammatory phenotypes (Keating et al. 2008). SNPs with a genotype 
missing rate greater than 95%, with an exact test of Hardy-Weinberg equilibrium P-value 
< 1.0 x 10-7 or a minor allele frequency (MAF) < 0.05 were excluded. Samples with a 
genotype missing rate greater than 90% were also excluded. This reduced our dataset to 
24, 837 individuals and 44,570 SNPs.  
 
     Non-founder individuals were also removed from the study population. To check for 
relatedness between individuals, identity-by-descent (IBD) estimates were calculated 
using PLINK (Purcell et al. 2007). For each pair of individuals with a ?̂? > 0.3, one 
individual was removed.  
 
     Finally, individual datasets with no missing phenotype data were created for each of 
the lipid outcomes measured. Within each of the datasets, SNPs were further tested for 
linkage disequilibrium (LD) – a SNP was removed from each pair of SNPs that had an 
LD (r2) ≥ 0.6. Genotypes were also imputed, to ensure there was no missing genotype 
information. The most common genotype for a given marker was used as the imputed 
genotype. Further details of the number of SNPs and individuals in each of these datasets 
can be found in Fig. 3.  
 
    Study participants in the replication dataset were from the eMERGE network.  The 
eMERGE network is a consortium of institutions with DNA from biorepositories linked 
to data from patient electronic medical records (EMR) (Gottesman et al. 2013).  The 
eMERGE set was genotyped with the Illumina660W GWAS platform and further 
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imputed using 1000 Genomes project data, as described previously (Verma et al. 2014).  
The replication set consisted of data from the Marshfield Clinic, Northwestern 
University, Group Health Cooperative, Mayo Clinic, and Vanderbilt University. After 
QC, the final eMERGE sample size was n=7,502 for all lipid traits. Details on quality 
control and phenotype extractions from the EMR have been published previously 
(Rasmussen-Torvik et al. 2012).  Briefly, each cohort tested for population stratification 
and relatedness, adjusting accordingly. The minimum variant and sample call rate 
threshold for all replication cohorts was 0.95 and 0.90, respectively. A Hardy-Weinberg 
equilibrium test P-value threshold of at least P < 1 x 10-6 was applied by each group. 
 
Marker Selection 
 
    To reduce the computational time burden and multiple hypothesis testing, additional 
parallel SNP filtering steps (main effect filter and Biofilter) were employed. These 
strategies have been implemented by other studies as two powerful options for gene-gene 
interaction analysis in large-scale genotype datasets (Sun et al. 2014).   
 
 
Main Effect Filter 
 
     SNPs were tested for their independent association with the continuous lipid outcome 
using linear regression (Asselbergs et al. 2012). SNPs with a main effect P-value < 0.01 
were selected for further analysis.  
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Biofilter 
 
    SNPs were also analyzed using Biofilter 2.0, a knowledge-based software package that 
enables the analysis and identification of multi-SNP models in large datasets (Bush et al. 
2009; Pendergrass et al. 2013). It has previously been used to identify predictive SNP-
SNP models for traits such as age-related cataract (Hall et al. 2015), multiple sclerosis 
(Bush et al. 2011), HIV pharmacogenetics (Grady et al. 2011) and HDL cholesterol 
(Turner et al. 2011). The software combines information from various online public 
knowledge databases to identify genes and SNPs that are most likely to interact with each 
other through their mutual participation in biological processes, signaling pathways and 
protein-protein interactions. Biofilter also provides an implication index, which measures 
the strength of the knowledge-based support for a putative interaction model. This is 
indicated by the sum of the number of supporting data sources for each of the genes in a 
given interaction. In our analyses, we included models if they were supported by at least 
five sources. This was a slightly more stringent implication index cut-off than those used 
in previous studies (Turner et al. 2011).  
 
Statistical Analyses 
 
Covariate Adjustment 
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     Quantitative lipid outcome values were regressed on age, sex, BMI, use of 
medications for lowering lipids, first ten principal components addressing population 
substructure, type II diabetes status and smoking status. The residual lipid outcome 
values from this regression model were then used as the continuous phenotypic outcome 
variable in QMDR analysis. Principal components were computed using EIGENSTRAT 
software (Price et al. 2006). 
 
Association Analysis using QMDR 
 
     SNPs obtained from the filtering procedures described above were tested for 
association with the corresponding continuous lipid outcome using QMDR. QMDR is an 
extension of the two-class MDR algorithm used to detect and characterize multi-SNP 
interactions in the context of a quantitative trait (Ritchie et al. 2001; Gui et al. 2013).  
 
    Originally, the MDR algorithm was designed as a data reduction method to enable the 
identification of multi-locus genotype combinations that are associated with high or low 
risk of a disease (Ritchie et al. 2001). For a dataset of m SNPs, k SNPs can be selected to 
study a k-order interaction. Next, a contingency table is constructed and case-control 
ratios are calculated for each of the possible multi-locus genotypes for these k SNPS. The 
case-control ratio for each multi-locus genotype is then compared to the case-control ratio 
for the whole dataset. If the genotype-specific case-control ratio exceeds the case-control 
ratio for the dataset, it is considered to be high-risk, otherwise it is considered to be low-
risk.  
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    However, in the case of QMDR, the algorithm compares the mean value of the 
phenotype for a specific multi-locus genotype, to the overall mean of the phenotype 
within the entire dataset. Consequently, a genotype combination is considered high-level 
if its mean phenotype value is larger than the overall mean of the phenotype. Otherwise, 
it is considered low-level. Finally, QMDR combines the ‘high-level’ and ‘low-level’ 
genotypes into separate groups and compares the phenotypic outcomes between these 
two groups using a T-test.  
 
    QMDR also involves a 10-fold cross-validation procedure similar to the original MDR 
algorithm. The data is divided into 10 portions – 9 portions are used as a training dataset 
and the remaining portion is used as a testing dataset. The algorithm repeats the 
procedure described above and calculates the overall mean of the phenotype separately 
for the training and the testing dataset. The training t-statistic is calculated for each k-way 
interaction in the training dataset. Next, the k-way model with the best training score is 
used to predict the case-control status in the testing dataset. The training t-statistic score 
is used to choose the best k-order interaction model and the highest testing t-statistic is 
used to select the best interaction model for the dataset.  
 
    In our analyses, we used QMDR to analyze filtered SNPs for all possible SNP-SNP 
interaction models that are associated with a given continuous lipid outcome (HDL-C, 
LDL-C, TC and TG) based on their training t-statistic scores. Amongst these models, the 
100 best overall SNP-SNP models were selected using their testing t-statistic scores. 
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Additionally, we used linear regression to adjust for the main effect of each SNP within a 
SNP-SNP model tested by QMDR. This was performed to increase our ability to identify 
pairwise interactions that are not primarily driven by the strong independent effects of the 
participating SNPs within a model. 
 
Permutation testing to assess statistical significance 
 
     We also performed 1000 permutations to establish a null distribution and determine 
the threshold for an α=0.05 significance level. Identical to our analysis procedure, the 100 
best SNP-SNP models were selected based on their t-statistic training and testing values 
for each permuted dataset. The null distribution built from the 100 best SNP-SNP models 
from all permutations and their corresponding t-statistic values was utilized to calculate 
P-values.  
 
Mapping SNPs to genes 
 
    SNPs within the statistically significant pairwise interactions for each quantitative lipid 
trait were mapped to a corresponding gene using dbSNP (build 139) and SCANdb 
(www.scandb.org).  
 
Integrated Multi-Species Prediction (IMP) web server 
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    We also used the Integrated Multi-Species Prediction (IMP) web server to query genes 
represented by the SNPs within identified interactions (Wong et al. 2012). IMP integrates 
biological evidence from multiple information sources such as experimentally verified 
information from gene expression studies, IntAct, MINT, MIPS, and BioGRID databases. 
The software mines empirical data to provide a probability score that two genes are 
involved in a functional and biological relationship. 
 
Replication Analyses 
 
    SNP-SNP models with a permutation P-value < 0.05 were chosen for replication in the 
eMERGE dataset (McCarty et al. 2011). We also identified all SNP-SNP models that 
were in LD with the identified significant models. SNPs that are in high LD (r2 > 0.8) 
with the SNPs in the interaction models, were identified using SNAP (Johnson et al. 
2008). This data was used to generate a list of ‘proxy’ SNP-SNP models representing the 
original significant interaction models. Both the statistically significant original models 
and the proxy models representing them were tested for replication. Table S4 shows the 
number of models tested per lipid quantitative trait. Additional details of the number of 
LD expanded models generated and tested for each original model are presented in Table 
S5. The same QMDR analysis procedure was performed as described earlier.  
 
Assessing the added variance in lipid traits explained by replicated pairwise 
interactions 
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    Linear regression models were used to assess the added variance of the quantitative 
lipid traits explained by the SNP-SNP interactions that were replicated in our independent 
dataset. The reduced regression model was built by including the main effects of each of 
the SNPs within our replicated interactions. The full regression model included the 
identified pairwise interactions in addition to the terms from the reduced model. Adjusted 
R2 values were used to assess the variance explained by both models. Additionally, a 
likelihood ratio test was used to compare both models. 
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Figure Captions 
 
Fig. 1 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of 
SNPs within pairwise interactions (P-value < 0.05) associated with HDL cholesterol 
level. LD diagram was generated using Haploview. Interactions between SNPs are shown 
with dotted lines. SNPs were mapped to corresponding genes using dbSNP (build 139) 
and SCANdb. (rs2952101 and rs6641322 on chromosome X are not shown here) 
 
Fig 2.  Functional relationship network generated from Integrated Multi-Species 
Prediction (IMP) from SNP-SNP interactions associated with (a) HDL-C and (b) LDL-C 
after main effect filtering (P-value < 0.05). SNPs were mapped to their respective genes 
and used to query IMP. Nodes in the network represent genes. Orange nodes are the 
genes that were queried. Edges between nodes represent a functional relationship 
between two genes. The color of the edge signifies the strength of the relationship 
confidence. Known relationships are highlighted in gold 
 
Fig. 3 Schematic design of study for the QMDR lipid traits association analysis 
 
Supporting Information 
 
Fig. S1 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of 
SNPs within pairwise interactions (P-value < 0.05) associated with LDL cholesterol 
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level. Interactions between SNPs are shown with dotted lines. LD diagram was generated 
using Haploview 
 
Fig. S2 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of 
SNPs within pairwise interactions (P-value < 0.05) associated with total cholesterol level. 
Interactions between SNPs are shown with dotted lines. LD diagram was generated using 
Haploview 
 
Fig. S3 Main effect filter analysis - underlying linkage disequilibrium (LD) structure of 
SNPs within pairwise interactions (P-value < 0.05) associated with triglyceride level. 
Interactions between SNPs are shown with dotted lines. LD diagram was generated using 
Haploview 
 
Fig. S4 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs 
within pairwise interactions (P-value < 0.05) associated with HDL cholesterol level. 
Interactions between SNPs are shown with dotted lines. LD diagram showing r2 values 
was generated using Haploview 
 
Fig. S5 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs 
within pairwise interactions (P-value < 0.05) associated with LDL cholesterol level. 
Interactions between SNPs are shown with dotted lines. LD diagram showing r2 values 
was generated using Haploview 
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Fig. S6 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs 
within pairwise interactions (P-value < 0.05) associated with total cholesterol level. 
Interactions between SNPs are shown with dotted lines. LD diagram showing r2 values 
was generated using Haploview 
 
Fig. S7 Biofilter analysis - underlying linkage disequilibrium (LD) structure of SNPs 
within pairwise interactions (P-value < 0.05) associated with triglyceride level. 
Interactions between SNPs are shown with dotted lines. LD diagram showing r2 values 
was generated using Haploview 
 
Table S1 Known biological roles of genes identified within SNP-SNP interactions 
associated with each lipid trait. Gene information found using GeneCards database 
(www.genecards.org, Accessed March 28, 2015) 
 
Table S2 Information for cohorts providing individual level data 
 
Table S3 Information of eMERGE cohorts providing individual level data for replication 
analyses 
 
Table S4 Number of original (non-proxy) and LD-expanded (proxy) SNP-SNP models 
tested for replication in eMERGE dataset. Numbers are shown for each lipid trait after 
using both filtering methods 
 
42 
Table S5 Number of LD-expanded (proxy) SNP-SNP models generated for each original 
discovered SNP-SNP model. Also shown are the number of SNP-SNP models tested for 
replication in eMERGE dataset per signal. Numbers are shown for each lipid trait after 
using both main effect and Biofilter filtering methods 
